RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Money4, Tran isn't required to own any direct shares yet since he's a new hire (has a 3 year window to buy), plus he just received a huge truckload of super low priced options. Lucky timing on his part, unlike Varney who got stuck with his truckload at much higher prices.

Concerning AD PET, Stoll said results at end of Q2-08. There's a 2nd CX-717 AD oriented trial planned also (functional MRI or another scanning type technology), scheduled to start in Q1-08.

RD - Scheduled to start in January with results approx end of March/early April. Trial to be run in Germany. There's also a 2nd RD trial planned, to start in Q2-08 with results in Q3-08.

CX-701 - The IND filing for Phase 1 in Q4-07. Trial will be in Europe. Could be ready for Phase 2 in H2-08, with potential targets AD, EDS, RD, and Stoll also mentioned possibly another try at ADHD.

Concerning a formal letter from FDA on the CX-717/ADHD IND denial, we haven't heard anything officially though perhaps Stoll will discuss it in the presentation on Wednesday. I'll repost Stoll's email response to Ombow from a couple weeks ago.